Table 2.
Levels of serum DPP-IV activity, sCD26 concentration, and anti-CD26/DPP-IV autoantibody isotypes according to demographic characteristics and origin of the cohort.
| Characteristic | DPP4 Mean ± SD (mU/mL) |
sCD26 Mean ± SD (ng/mL) |
IgA Mean ± SD (Abs450nm) |
IgG Mean ± SD (Abs450nm) |
IgM Mean ± SD (Abs450nm) |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | p value | N | p value | N | p value | N | p value | N | p value | ||||||
| Sex | |||||||||||||||
| Men | 182 | 45.20 ± 24.87 | 0.002 a | 189 | 443.19 ± 129.39 | 0.176a | 76 | 0.26 ± 0.12 | 0.530a | 76 | 0.27 ± 0.08 | 0.328a | 76 | 0.17 ± 0.09 | 0.146a |
| Women | 146 | 37.64 ± 19.69 | 144 | 461.87 ± 117.87 | 48 | 0.28 ± 0.11 | 49 | 0.29 ± 0.08 | 49 | 0.20 ± 0.13 | |||||
| Age (years) | |||||||||||||||
| ≤50 | 126 | 39.98 ± 22.61 | 126 | 452.22 ± 110.88 | 54 | 0.25 ± 0.10 | 55 | 0.27 ± 0.08 | 55 | 0.18 ± 0.08 | |||||
| 51-60 | 95 | 41.55 ± 18.85 | 0.206b | 94 | 458.03 ± 98.92 | 0.494b | 40 | 0.26 ± 0.11 | 0.062b | 40 | 0.29 ± 0.10 | 0.716b | 40 | 0.19 ± 0.14 | 0.296b |
| ≥61 | 50 | 35.15 ± 19.35 | 51 | 436.68 ± 94.06 | 29 | 0.31 ± 0.13 | 29 | 0.27 ± 0.07 | 29 | 0.15 ± 0.10 | |||||
| Group | |||||||||||||||
| CTG (n = 50) | 50 | 43.51 ± 15.86 | 0.542a | 50 | 459.50 ± 103.48 | 0.528a | 25 | 0.28 ± 0.08 | 0.863a | 25 | 0.27 ± 0.10 | 0.673a | 25 | 0.24 ± 0.15 | 0.005 a |
| HCU (n = 447) | 434 | 41.95 ± 25.02 | 443 | 448.58 ± 117.37 | 112 | 0.28 ± 0.13 | 113 | 0.28 ± 0.08 | 113 | 0.17 ± 0.09 | |||||
| HCU group relative to FIT | |||||||||||||||
| Negative for FIT (n = 138) | 137 | 37.44 ± 22.13 | 0.249a | 135 | 451.98 ± 95.21 | 0.652a | 22 | 0.28 ± 0.11 | 0.535a | 23 | 0.28 ± 0.08 | 0.851a | 23 | 0.17 ± 0.08 | 0.842a |
| Positive for FIT (n = 86) | 84 | 40.92 ± 20.97 | 86 | 445.49 ± 116.75 | 77 | 0.26 ± 0.12 | 77 | 0.28 ± 0.08 | 77 | 0.16 ± 0.09 | |||||
FIT: faecal immunochemical test; aStudent's t test; bANOVA test.